On January 4, 2016, Fredric N. Eshelman has given an investor presentation to shareholders of Puma Biotechnology, Inc. in connection with its consent solicitation. In addition, Fredric N. Eshelman wrote a letter to shareholders of the Company asking their support in adding 4 additional members to the current 5 member Board of the Company.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.38 USD | +4.64% | +9.87% | -24.13% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.13% | 156M | |
+38.65% | 39.1B | |
-7.65% | 38.76B | |
+27.99% | 31.24B | |
+13.04% | 25.9B | |
-13.50% | 25.8B | |
+45.58% | 14.06B | |
+39.19% | 13.12B | |
-7.04% | 11.32B | |
-11.98% | 10.68B |
- Stock Market
- Equities
- PBYI Stock
- News Puma Biotechnology, Inc.
- Fredric N. Eshelman Gives Presentation to Shareholders of Puma Biotechnology